CLENE INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3517 USD | +3.47% |
|
+5.62% | +18.58% |
Chart calendar Clene Inc.
228cb732ca4596c.zhjNEEHjDzAajTRdbnTwJVmho2cXwWN8MLWHVQWJvkI.m3qDfRe3X1xZ22wyNiWRET6M7lVWhjBLUvv2DXb4hwuJIaJZBY1XYjfJBA~6029f377da2d41399b9e6d0d773a25bc
Upcoming events on Clene Inc.
Past events on Clene Inc.
| 13/04/2024 | American Academy of Neurology Meeting |
| 18/03/2024 08:30 pm | ROTH Conference |
| 13/03/2024 05:30 pm | Q4 2023 Earnings Release |
| 29/02/2024 | Americas Committee for Treatment and Research in Multiple Sclerosis Meeting |
| 28/02/2024 10:30 pm | Renmark Virtual Non-Deal Roadshow |
| 07/11/2023 06:30 pm | Q3 2023 Earnings Release |
| 26/09/2023 11:05 pm | Cantor Global Healthcare Conference - Panel |
| 12/09/2023 08:30 pm | H.C. Wainwright Global Investment Conference |
| 14/08/2023 05:30 pm | Q2 2023 Earnings Release |
| 10/08/2023 09:00 pm | Canaccord Genuity Growth Conference |
| 22/06/2023 10:30 pm | Maxim Group Virtual Healthcare Conference |
| 09/05/2023 08:30 pm | Annual General Meeting |
| 25/04/2023 09:15 pm | American Academy of Neurology Meeting - James Berry, MD, MPH |
| 25/04/2023 06:45 pm | American Academy of Neurology Meeting - Sabrina Paganoni, MD, Ph.D |
| 25/04/2023 06:45 pm | American Academy of Neurology Meeting - Michael Barnett, Ph.D |
| 22/03/2023 11:30 pm | Roadshow - Renmark |
| 14/03/2023 01:00 am | ROTH Conference |
| 09/03/2023 06:00 pm | Drug Trail Results Call |
| 08/03/2023 01:30 am | Roadshow - Renmark |
| 23/01/2023 10:30 pm | Non-Deal Roadshow - Renmark Financial Communications Inc |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,21 0,20 3% | 0,72 0,60 19.98% | 0,47 0,34 38.83% | 0,65 0,56 17.41% | 0,44 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | -47,4 -47,2 -0.4% | -38,8 -40,6 4.35% | -40,2 |
|
EBIT Million USD | Released Forecast Spread | -16,3 | -20,2 -19,8 -1.87% | -50,0 -46,6 -7.2% | -48,4 -46,3 -4.52% | -40,5 -40,2 -0.78% | -40,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -18,9 -26,7 29.32% | -10,2 -21,6 52.91% | -29,9 -38,6 22.45% | -49,5 -48,7 -1.72% | -43,0 |
|
Net income Million USD | Released Forecast Spread | 0,00 | -19,3 -26,7 27.8% | -9,74 -24,8 60.75% | -29,9 -38,6 22.45% | -49,5 -48,7 -1.72% | -43,0 |
|
EPS USD | Released Forecast Spread | -0,13 | -0,32 -0,45 28.04% | -0,16 -0,40 59.49% | -0,46 -0,58 20.1% | -0,47 -0,46 -3.3% | -0,30 |
| Announcement Date | 10/09/20 | 29/03/21 | 11/03/22 | 13/03/23 | 13/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,20 0,09 113.98% | 0,03 0,10 -70.73% | 0,04 0,07 -51% | 0,17 0,07 134.22% | 0,23 0,12 102.47% | 0,11 0,12 -6.96% | 0,27 0,11 142.34% | 0,11 0,12 -8.73% | 0,17 0,10 78.95% | 0,12 | 0,12 | 0,13 | 0,13 | 0,10 |
|
EBITDA Million USD | Released Forecast Spread | -13,1 -14,7 10.61% | -13,3 -13,9 3.91% | -9,57 -14,4 33.53% | -11,4 -10,9 -4.78% | -10,3 -11,1 6.94% | -9,89 -11,3 12.05% | -9,10 -11,1 17.99% | -9,51 -10,0 4.92% | -9,60 | -10,1 | -10,2 | -10,4 | ||
|
EBIT Million USD | Released Forecast Spread | -14,1 -10,7 -31.25% | -13,3 -13,1 -1.56% | -13,6 -13,2 -3.28% | -9,81 -13,6 28.11% | -11,7 -9,58 -21.84% | -10,7 -11,0 2.15% | -10,3 -10,7 3.15% | -9,54 -10,4 8.2% | -9,93 -9,62 -3.21% | -9,58 | -9,72 | -9,96 | -10,5 | -8,90 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 4,21 -10,6 139.56% | -13,4 -13,1 -1.94% | -4,53 -13,3 65.96% | -11,0 -14,3 23.48% | -1,05 -9,59 89.01% | -11,8 -11,2 -4.72% | -25,1 -10,9 -130.06% | -2,42 -11,1 78.25% | -10,2 -9,30 -9.4% | -10,4 | -10,7 | -10,9 | -11,1 | -9,00 |
|
Net income Million USD | Released Forecast Spread | 4,42 -10,6 141.59% | -13,4 -13,1 -1.94% | -4,53 -13,3 65.96% | -11,0 -14,3 23.48% | -1,05 -9,59 89.01% | -11,8 -11,2 -4.72% | -25,1 -10,9 -130.06% | -2,42 -11,1 78.25% | -10,2 -9,30 -9.4% | -10,4 | -10,7 | -10,9 | -11,1 | -9,00 |
|
EPS USD | Released Forecast Spread | 0,07 -0,16 143.75% | -0,21 -0,19 -8.62% | -0,07 -0,20 65.25% | -0,17 -0,22 21.19% | 0,00 -0,12 - | -0,15 -0,14 -3.96% | -0,29 -0,12 -136.04% | -0,02 -0,09 77.78% | -0,06 -0,07 16.67% | -0,08 | -0,08 | -0,08 | -0,07 | -0,07 |
| Announcement Date | 11/03/22 | 09/05/22 | 15/08/22 | 07/11/22 | 13/03/23 | 12/05/23 | 14/08/23 | 07/11/23 | 13/03/24 | - | - | - | - | - |
| Today 01:35 am | EXELIXIS, INC.: Q1 2024 Earnings Release |
| 01/05/2024 | SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release |
| 01/05/2024 | MACROGENICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | REGENXBIO INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | DECIPHERA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 04:30 pm | NEUROCRINE BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 02/05/2024 01:35 am | SAREPTA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | ZENTALIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | DENALI THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | GERON CORPORATION: Q1 2024 Earnings Release |
Past sector events for Clene Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CLNN Stock
- Calendar Clene Inc.
